Edition:
United States

Pfizer Inc (PFE)

PFE on New York Consolidated

36.83USD
29 Jul 2016
Change (% chg)

$0.16 (+0.42%)
Prev Close
$36.67
Open
$36.68
Day's High
$36.92
Day's Low
$36.65
Volume
8,268,676
Avg. Vol
33,008,427
52-wk High
$37.19
52-wk Low
$28.25

Summary

Name Age Since Current Position

Ian Read

62 2011 Chairman of the Board, Chief Executive Officer

Frank D'Amelio

58 2010 Chief Financial Officer, Executive Vice President - Business Operations

Albert Bourla

53 2016 Group President - Vaccines, Oncology and Consumer Healthcare Business, Global Innovative Pharma Business

Mikael Dolsten

57 2010 President - Worldwide Research and Development

John Young

51 2014 Group President - Global Established Pharma Business

Rady Johnson

54 2013 Executive Vice President, Chief Compliance and Risk Officer

Douglas Lankler

50 2014 Executive Vice President, General Counsel

Charles Hill

60 2010 Executive Vice President - Worldwide Human Resources

Freda Lewis-Hall

61 2010 Executive Vice President, Chief Medical Officer

Anthony Maddaluna

63 2013 Executive Vice President, President - Pfizer Global Supply

Laurie Olson

52 2012 Executive Vice President - Strategy, Portfolio and Commercial Operations

Sally Susman

54 2010 Executive Vice President - Corporate Affairs

Dennis Ausiello

70 2015 Lead Independent Director

W. Don Cornwell

68 1997 Independent Director

Joseph Echevarria

59 2015 Independent Director

Frances Fergusson

71 2009 Independent Director

Helen Hobbs

63 2011 Independent Director

James Kilts

68 2007 Independent Director

Shantanu Narayen

52 2013 Independent Director

Suzanne Nora Johnson

58 2007 Independent Director

Stephen Sanger

69 2009 Independent Director

James Smith

56 2014 Independent Director

Biographies

Name Description

Ian Read

Mr. Ian C. Read is Chairman of the Board, Chief Executive Officer of the Company. He served as Senior Vice President and Group President of the Worldwide Biopharmaceutical Businesses, which he led from 2006 through December 2010. In that role, he oversaw five global business units—Primary Care, Specialty Care, Oncology, Established Products and Emerging Markets. Mr. Read began his career with Pfizer in 1978 as an operational auditor. He worked in Latin America through 1995, holding positions including Chief Financial Officer, Pfizer Mexico, and Country Manager, Pfizer Brazil. In 1996, he was appointed President of Pfizer’s International Pharmaceuticals Group, with responsibility for Latin America and Canada. He became Executive Vice President, Europe, in 2000, was named a Corporate Vice President in 2001, and assumed responsibility for Canada, in addition to Europe, in 2002. Mr. Read later became accountable for operations in both the Africa/Middle East region and Latin America as well. Director of Kimberly-Clark Corporation. Mr. Read serves on the Boards of Pharmaceutical Research and Manufacturers of America (PhRMA) and the Partnership of New York City. He is member of the U.S.-China Business Council.

Frank D'Amelio

Mr. Frank A. D'Amelio is Chief Financial Officer, Executive Vice President - Business Operations of the Company. He was Senior Vice President and Chief Financial Officer from September 2007 until December 2010. Prior to joining Pfizer, he was Senior Executive Vice President of Integration and Chief Administrative Officer of Alcatel-Lucent from November 2006 until August 2007. Director of Zoetis Inc. and of Humana Inc. and Chair of the Humana Audit Committee. He is a Director of the Independent College Fund of New Jersey and the Gillen Brewer School.

Albert Bourla

Mr. Albert Bourla has been appointed as Group President - Vaccines, Oncology and Consumer Healthcare Business, Global Innovative Pharma Business of the Company. He was President and General Manager of Established Products Business Unit from December 2010 until December 2013. Area President Europe, Africa, Asia and Pacific of Pfizer Animal Health from 2009 until November 2010. Area President Europe, Africa and Middle East of Pfizer Animal Health from 2005 until 2009.

Mikael Dolsten

Dr. Mikael Dolsten, M.D., Ph.D., is President - Worldwide Research and Development of the Company. He was Senior Vice President; President of Worldwide Research and Development from May 2010 until December 2010. Senior Vice President; President of Pfizer BioTherapeutics Research & Development Group from October 2009 until May 2010. He was Senior Vice President of Wyeth and President, Wyeth Research from June 2008 until October 2009. He was a Private Equity Partner at Orbimed Advisors, LLC from January 2008 until June 2008. Director of Karyopharm Therapeutics Inc.

John Young

Mr. John D. Young is Group President - Global Established Pharma Business of the Company. He was President and General Manager, Pfizer Primary Care from June 2012 until December 2013. Primary Care Business Unit’s Regional President for Europe and Canada from 2009 until June 2012. U.K. Country Manager from 2007 until 2009.

Rady Johnson

Mr. Rady A. Johnson, II, is Executive Vice President, Chief Compliance and Risk Officer of the Company. He was Senior Vice President and Associate General Counsel from October 2006 until December 2013.

Douglas Lankler

Mr. Douglas M. Lankler is Executive Vice President, General Counsel of the Company. He was Corporate Secretary from January 2014 until February 2014. Executive Vice President, Chief Compliance and Risk Officer from February 2011 until December 2013. Executive Vice President, Chief Compliance Officer from December 2010 until February 2011. Senior Vice President and Chief Compliance Officer from January 2010 until December 2010. Senior Vice President, Deputy General Counsel and Chief Compliance Officer from August 2009 until January 2010. Senior Vice President, Associate General Counsel and Chief Compliance Officer from October 2006 until August 2009.

Charles Hill

Mr. Charles H. Hill, III, is Executive Vice President - Worldwide Human Resources of the Company. He was Senior Vice President, Human Resources for Worldwide Biopharmaceuticals Businesses from 2008 through December 2010. Vice President, Human Resources, Worldwide Pharmaceutical Operations from 2004 through 2008. Director of Zoetis Inc. from July 2012 until June 2013.

Freda Lewis-Hall

Dr. Freda C. Lewis-Hall, M.D., is Executive Vice President, Chief Medical Officer of the Company. She was Senior Vice President, Chief Medical Officer from May 2009 until December 2010. Previously, she was Chief Medical Officer and Executive Vice President, Medicines Development at Vertex Pharmaceuticals from June 2008 until May 2009. Dr. Lewis-Hall was Senior Vice President, U.S. Pharmaceuticals, Medical Affairs for Bristol-Myers Squibb Company from 2003 until May 2008. Director of Tenet Healthcare Corporation.

Anthony Maddaluna

Mr. Anthony J. Maddaluna is Executive Vice President, President - Pfizer Global Supply of the Company. He was President, Pfizer Global Supply from 2011 until December 2012. Senior Vice President, Strategy & Supply Network Transformation from 2009 until December 2010. Vice President, Strategy & Supply Network Transformation from 2008 until 2009. Vice President and Team Leader, Europe from 1998 until 2008 including responsibility for global logistics and strategic planning from 2005 through 2008. Mr. Maddaluna represents Pfizer on the National Association of Manufacturers (NAM) and is a member of the NAM Executive Committee. Director of Albany Molecular Research Inc.

Laurie Olson

Ms. Laurie J. Olson serves as the Executive Vice President - Strategy, Portfolio and Commercial Operations of the Company. She was Senior Vice President - Strategy and Portfolio Management from 2011 until July 2012. Senior Vice President - Portfolio Management and Analytics from 2008 until 2010. Since joining Pfizer in 1987 as an Analyst in the Company’s marketing research organization, Ms. Olson has served in a variety of marketing leadership positions with increasing responsibility in both the Company’s U.S. and global commercial organizations.

Sally Susman

Ms. Sally Susman is Executive Vice President - Corporate Affairs of the Company. She was Senior Vice President, Policy, External Affairs and Communications from December 2009 until December 2010. Senior Vice President and Chief Communications Officer from February 2008 until December 2009. Prior to joining Pfizer, Ms. Susman held senior level positions at The Est é e Lauder Companies, including Executive Vice President from 2004 to January 2008. Director of WPP plc.

Dennis Ausiello

Dr. Dennis A. Ausiello, M.D., is Lead Independent Director of Pfizer Inc., with effective from April 2015. He is Director, Center for Assessment Technology and Continuous Health (CATCH). Physician-in-Chief, Emeritus at Massachusetts General Hospital and Chief of Medicine at Massachusetts General Hospital from 1996 until April 2013. Jackson Distinguished Professor of Clinical Medicine at Harvard Medical School. He is president of the Association of American Physicians in 2006. He also serves as a member of the Institute of Medicine of the National Academies of Science and a Fellow of the American Academy of Arts and Sciences. He is Director of Alnylam Pharmaceuticals, Inc., Seres Therapeutics, Inc., TARIS BioMedical LLC and several nonprofit organizations.

W. Don Cornwell

Mr. W. Don Cornwell is Independent Director of Pfizer Inc., since February 1997. He has been Chairman of the Board and Chief Executive Officer of Granite Broadcasting Corporation from 1988 until his retirement in August 2009 and Vice Chairman until December 2009. He is Granite Broadcasting Corporation filed for voluntary reorganization under Chapter 11 of the U.S. Bankruptcy Code in December 2006 and emerged from its restructuring in June 2007. He is Director of American International Group, Inc. and Avon Products, Inc. Director of the Edna McConnell Clark Foundation. He also serves as a Director of the Wallace Foundation from 2002 until 2012 and previously served as a Director of CVS Caremark (including two years as Chair of its Compensation Committee) for over 10 years. He is Trustee of Big Brothers/Sisters of New York.

Joseph Echevarria

Mr. Joseph J. Echevarria is Independent Director of the Company. Mr. Echevarria retired as Chief Executive Officer (CEO) of Deloitte LLP, a global provider of professional services, in August 2014. He had been with the firm for 36 years and served in various leadership roles, including Deputy Managing Partner, Southeast Region Audit Managing Partner, U.S. Managing Partner and Chief Operating Officer. He was appointed CEO in 2011. Mr. Echevarria serves as a Director of The Bank of New York Mellon Corporation. He is a member of the President's Export Council and the Presidential Commission on Election Administration and also serves as Chair of President Obama’s My Brother’s Keeper Alliance. He serves on the Board of Trustees of the University of Miami.

Frances Fergusson

Dr. Frances Daly Fergusson, Ph.D., is Independent Director of Pfizer Inc., since September 25, 2009. Dr. Fergusson is President Emeritus of Vassar College since 2006 and President from 1986 to 2006. She Served on the Mayo Clinic Board for 14 years, the last four years as its Chairman, and as President of the Board of Overseers of Harvard University from 2007 through 2008, Director of Wyeth from 2005 until 2009. Director of Mattel, Inc. She serves as a Trustee of the J. Paul Getty Trust (executive committee) and Second Stage Theatre, and as a Director on the executive committee of The John and Mable Ringling Museum of Art Foundation, Inc.

Helen Hobbs

Dr. Helen H. Hobbs, M.D., is Independent Director of Pfizer Inc., since December 12, 2011. She is Investigator of the Howard Hughes Medical Institute since 2002, Professor of Internal Medicine and Molecular Genetics and Director of the McDermott Center for Human Growth and Development at the University of Texas Southwestern Medical Center. She is Member of the American Society for Clinical Investigation and the Association of American Physicians. She Elected to the National Academy of Medicine in 2004, the American Academy of Arts and Sciences in 2006, and the National Academy of Sciences in 2007. She received both the Clinical Research Prize (2005) and Distinguished Scientist Award (2007) from the American Heart Association. In 2012, she received the inaugural International Society of Atherosclerosis Prize and in 2015 she received both the Pearl Meister Greengard Award and the Breakthrough Prize in Life Sciences.

James Kilts

Mr. James Marshall Kilts is Independent Director of Pfizer Inc., since September 27, 2007. He is Founding Partner, Centerview Capital, a private equity firm, since 2006. He is Vice Chairman, The Procter & Gamble Company (Procter & Gamble), from 2005 to 2006 and Chairman and Chief Executive Officer, The Gillette Company (Gillette), from 2001 to 2005 and President, Gillette, from 2003 to 2005. He is President and Chief Executive Officer, Nabisco Group Holdings Corporation (Nabisco), from 1998 until its acquisition in 2000. He is Non-Executive Director of the Board of Nielsen Holdings N.V., Chairman of the Board of Nielsen Holdings N.V. (from January 2011 until December 2013) and Chairman of the Nielsen Company B.V. (from 2009 until 2014), Director of MetLife, Inc., Chairman of Big Heart Pet Brands until March 2015 and Director of Meadwestvaco Corporation until April 2014. He is Emeritus Trustee of Knox College and Trustee of the University of Chicago, a member of the Board of Overseers of Weill Cornell Medical College, and Founder and Co-Chair, Steering Committee, of the Kilts Center for Marketing at the University of Chicago Booth School of Business.

Shantanu Narayen

Mr. Shantanu Narayen is Independent Director of Pfizer Inc., since September 27, 2013. Mr. Narayen is President and Chief Executive Officer and Director of Adobe Systems Incorporated (Adobe), a producer of creative and digital marketing software. Prior to his appointment as CEO in December 2007, Mr. Narayen held various leadership roles at Adobe, including President and Chief Operating Officer, Executive Vice President of Worldwide Products, and Senior Vice President of Worldwide Product Development. Director of Dell Inc. from 2009 until October 2013 and Director of Metavante Technologies Inc. from 2007 until 2009. He serves as President of the Board of Adobe Foundation, which funds philanthropic initiatives around the world.

Suzanne Nora Johnson

Ms. Suzanne Nora Johnson is Independent Director of Pfizer Inc., since September 27, 2007. She is Retired Vice Chairman, Goldman Sachs Group, Inc. (Goldman Sachs), since 2007. During her 21-year tenure with Goldman Sachs, she served in various leadership roles, including Chair of the Global Markets Institute, Head of Global Research, and Head of Global Health Care. She is Director of American International Group, Inc., Intuit Inc. and Visa Inc. She is a member of the Board of Governors of the American Red Cross, Vice Chair, Board of Trustees of The Brookings Institution, Co-Chairman of the Board of Trustees of the Carnegie Institution of Washington and member of the Board of Trustees of the University of Southern California.

Stephen Sanger

Mr. Stephen W. Sanger is Independent Director of Pfizer Inc., since February 1, 2009. He served as Chairman of General Mills, Inc. (General Mills), a packaged food producer and distributor, from 1995 until his retirement in 2008 and its Chief Executive Officer from 1995 to 2007. He is former Chairman of the Grocery Manufacturers of America. He is Recipient of the Woodrow Wilson Award for Public Service in 2009. He Chaired the Fiscal Policy Committee of the Business Roundtable and served as a director of Catalyst. Director of Wells Fargo & Company. He is Director of Target Corporation from 1996 until 2013.

James Smith

Mr. James Clifton Smith is Independent Director of the Company. Mr. Smith is President and Chief Executive Officer and Director of Thomson Reuters Corporation, a provider of intelligent information for businesses and professionals, since January 2012 and its Chief Operating Officer from September 2011 to December 2011 and Chief Executive Officer, Thomson Reuters Professional Division, from 2008 to 2011. Prior to the acquisition of Reuters Group PLC by The Thomson Corporation (Thomson) in 2008, he served as Chief Operating Officer of Thomson and as President and Chief Executive Officer of Thomson Learning’s Academic and Reference Group. He is a member of the International Business Council of the World Economic Forum, the International Advisory Boards of British American Business and the Atlantic Council.